Navigation Links
Gandek Joins QualityMetric to Lead International Research Effort
Date:4/24/2008

Outcomes Researcher and Translation Specialist Barbara Gandek Joins

QualityMetric Incorporated

LINCOLN, R.I., April 24 /PRNewswire/ -- As part of its continuing commitment to international research, QualityMetric today announced that Barbara Gandek, MS has accepted the position of Senior Scientist and Director of International Research & Development. Gandek will report to James E. Dewey, PhD, Chief Innovation & Research Officer and continue to work closely with her colleague of 19 years, John E. Ware Jr., PhD, QualityMetric's founder and CEO.

During her career, Gandek has authored or co-authored more than 40 peer-reviewed articles, many of which fostered the development of health outcomes measurement around the world. Barbara spearheaded the ongoing effort to translate the entire suite of adult SF Health Surveys for use in more than 75 countries and co-edited a special issue of the Journal of Clinical Epidemiology that summarized the work of the International Quality of Life Assessment (IQOLA) Project in the 1990's. She has also been involved in the development of five of the SF manuals, including the most recently published "User's Manual for the SF-36v2 Health Survey - Second Edition."

"QualityMetric is recommitting itself to fostering international outcomes research and to developing additional norms for countries outside the U.S.," says Ware. "No one is better qualified to lead this effort than Barbara."

For years, Gandek worked closely with her colleagues at QualityMetric as a Scientist and Director at the Health Assessment Lab (HAL). Before this, she worked at New England Medical Center's Health Institute, primarily on the IQOLA Project and the Medical Outcomes Study. She holds a Bachelor of Arts degree in Economics from Swarthmore College and a Master of Science in Health Policy & Management from Harvard School of Public Health. Ms. Gandek is an Instructor at Tufts University School of Medicine.

"While at HAL, Barbara was always very supportive of our efforts with the Office of Grants and Scholarly Research," added Dewey. "Having her on the staff full time to direct our international efforts will be a great boost to QualityMetric and to outcomes researchers around the world."

About QualityMetric:

QualityMetric Incorporated works with the world's largest healthcare and life sciences companies to measure health outcomes. Our products help market new drugs and biologics, track health improvement or decline, screen populations for disease, and identify future health risks. QualityMetric's patient-reported outcome (PRO) surveys provide scientifically valid assessments of both physical and mental health. Our PROs include the SF-36v2(R), SF-12v2(R), and SF-8(TM) Health Surveys, SF-10(TM) Health Survey for Children, Asthma Control Test (ACT(TM)), Pain Impact Questionnaire (PIQ-6(TM)), and DYNHA(R) Dynamic Health Assessments. Our Outcomes Insight Consulting(TM) Group can develop customized PROs and provide in-depth analysis of the results. QualityMetric's founder and CEO, John E. Ware Jr., PhD is a thought-leader in the field of psychometrics and health outcome measurement. Visit us at http://www.qualitymetric.com


'/>"/>
SOURCE QualityMetric
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Damian DellAnno Joins Formation Capital as Chief Operating Officer
2. John D. Baxter, M.D. Joins Bionovos Board of Directors
3. Susan Byrne joins GHG Grey Healthcare Group as EVP, Strategy and Business Development, Europe, a Newly-Created Position
4. Jennifer Samuels Joins GHG Grey Healthcare Group as Executive Vice President, Account Services
5. William F. Northrup, III, M.D. Joins CryoLife as Vice President of Medical Relations and Education
6. Medical Device Manufacturers Association Joins the National Healthcare Career Network
7. MemorialCare Joins Forces with Physician Partners to Advocate for a Balanced, Fiscally Responsible Healthcare System
8. Mary Cheney Joins the Cheney Cardiovascular Institute Board of Directors
9. U.S. Joins Case Against Cincinnati Health Care Facilities Alleging Kickbacks for Cardiac Services
10. Morgan Fairchild Joins Neurologists, Emergency Physicians and the American Stroke Association to Educate the Public About Stroke Symptoms
11. SCI Real Estate Investments Joins City of Hope to Fight Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... Datos Health , ... partnership with Med-e-Mass , the largest Electronic Medical Records (EMR) provider in South ... care plan incentives to a patient’s remote health progress, empowering the patient to take ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be ... conditions and has helped many women become pregnant upon treating their diagnosis. ... and simple outpatient evaluations. We can provide the necessary information to diagnose ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to learn more about ... ) that demonstrates how this advanced plant breeding technology is a more efficient ... fewer resources. It highlights the business’ principles, research and collaboration efforts in this ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... have signed an agreement to be the preferred physical therapy provider for Derby ... returning them to Derby City CrossFit as quickly and effectively as possible, ProRehab’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 Mn ... by 2024, expanding at a CAGR of 5.6% from 2016 ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
Breaking Medicine Technology: